Recruitment of dendritic cells using 'find-me' signaling microparticles for personalized cancer immunotherapy.
Sign Up to like & getrecommendations! Published in 2022 at "Biomaterials"
DOI: 10.1016/j.biomaterials.2022.121412
Abstract: Therapeutic cancer vaccines have attracted attention because of their potential to prime cytotoxic T cells, which are highly antigen (Ag)-specific, allowing personalized cancer immunotherapy. However, because of their low immunogenicity, cancer vaccines have been used… read more here.
Keywords: cancer; personalized cancer; cancer immunotherapy; find signaling ... See more keywords